MedPath

Zetia

These highlights do not include all the information needed to use ZETIA safely and effectively. See full prescribing information for ZETIA. ZETIA (ezetimibe) TabletsInitial U.S. Approval: 2002

Approved
Approval ID

582e1593-1e6c-4ce8-8bae-134fbc3a66f0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ezetimibe

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-778
Application NumberNDA021445
Product Classification
M
Marketing Category
C73594
G
Generic Name
Ezetimibe
Product Specifications
Route of AdministrationORAL
Effective DateJuly 28, 2009
FDA Product Classification

INGREDIENTS (7)

cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
EzetimibeActive
Quantity: 10 mg in 1 1
Code: EOR26LQQ24
Classification: ACTIB
povidoneInactive
Code: FZ989GH94E
Classification: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
sodium lauryl sulfateInactive
Code: 368GB5141J
Classification: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zetia - FDA Drug Approval Details